1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Melissa Parks arrived unannounced on Thursday June 27, 2024, to complete and deliver findings for a complaint received on 5/8/2024. LPA met with Administrator Rouzbeh and explained the purpose of the visit.
Throughout the course of the investigation, LPA interviewed facility staff including the Administrator, Resident Services Director, Wellness Director, med techs, and caregivers. LPA reviewed R1’s file including PRN authorization, controlled drug records, communication with primary physician, resident assessment, physician reports, resident notes, physician orders, and PRN MAR.
LPA interviewed staff who revealed that R1 is able to communicate when they are in pain. R1 had PRN orders for Tramadol 50mg for moderate oto severe pain and acetaminophen 325 mg as needed for pain. No staff interviews revealed that R1 was ever refused pain medication. LPA did review a faxed message to R1’s primary physician, requesting a refill order for Tramadol. R1 has a primary diagnosis of CHF exacerbation and mild cognitive impairment. R1, at times, has refused to get out of bed. No staff |